LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.76 | 17.25 | 6280 | 6047 | 1.0384 | 1.0089 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.74 | 17.25 | 5045 | 6109 | 0.8258 | 0.9553 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.74 | 17.25 | 584 | 6109 | 0.0956 | 0.5158 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.74 | 17.25 | 6407 | 6109 | 1.0487 | 1.0113 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.71 | 17.25 | 5163 | 6184 | 0.8349 | 0.9579 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.71 | 17.25 | 556 | 6184 | 0.0899 | 0.5057 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.71 | 17.25 | 6587 | 6184 | 1.0651 | 1.0149 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 17.25 | 5301 | 6239 | 0.8496 | 0.9620 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 17.25 | 285 | 6239 | 0.0457 | 0.3910 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 17.25 | 6699 | 6239 | 1.0737 | 1.0168 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.06 | 17.25 | 140 | 143 | 0.9776 | 0.9852 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.06 | 17.25 | 463 | 143 | 3.2329 | 1.9372 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.03 | 17.25 | 216 | 273 | 0.7902 | 0.8853 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.03 | 17.25 | 744 | 273 | 2.7217 | 1.5711 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.01 | 17.25 | 393 | 389 | 1.0090 | 1.0040 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.01 | 17.25 | 852 | 389 | 2.1874 | 1.3803 | MN20160310_N02 | L16 |